Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China

Contributed by: Business Wire

Logo

Images

Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China (Photo: Business Wire)

Business Wire embedded0

Tags

Research

Genetics

Clinical Trials

Biotechnology

Health

Pharmaceutical

General Health

Other Science

Science

Gritgen Therapeutics Co., Ltd.

More Like This

Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A

PR Newswire associated0

GenSci Launches Global Innovation Hub in Shanghai

WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

WuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

PR Newswire associated0

WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing

Thermo Fisher Scientific announces the opening of a new site in the Netherlands specializing in ambient to cryogenic storage, clinical and commercial packaging, labeling, and distribution, and clinical QP release services (Photo: Business Wire)

Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development